Cargando…
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities
The coronavirus disease-2019 (COVID-19) pandemic has resulted in a proliferation of clinical trials designed to slow the spread of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Many therapeutic agents that are being used to treat patients with COVID-19 are repurposed treatments for i...
Autores principales: | Ky, Bonnie, Mann, Douglas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164888/ https://www.ncbi.nlm.nih.gov/pubmed/32313885 http://dx.doi.org/10.1016/j.jaccao.2020.04.002 |
Ejemplares similares
-
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities
por: Ky, Bonnie, et al.
Publicado: (2020) -
Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
por: Lenihan, Daniel J., et al.
Publicado: (2019) -
Cardio-Oncology: Understanding the Intersections Between Cardiac Metabolism and Cancer Biology
por: Karlstaedt, Anja, et al.
Publicado: (2021) -
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity
por: Minasian, Lori M., et al.
Publicado: (2019) -
A Cardio-Oncology Cardiovascular Prevention Framework
por: Marvel, Françoise A., et al.
Publicado: (2019)